Monopar Therapeutics
MNPR
83.78
+4.21
+5.29%
Monopar Therapeutics
US · MNPR
#3671 by market cap
Listed 2019
83.78
+4.21
+5.29%
Live - 5344 symbols - heartbeat 33s ago
· 2026-10-08 08:54
Pre-market
84.54
+0.91%
After-hours
83.80
+0.02%
Overnight
83.03
-0.90%
- Market cap
- 562.35M
- P/E (TTM)i
- -38.08
- P/Bi
- 4.30
- EPSi
- -1.85
- Div yieldi
- 0.00%
- 52W posi
- 45%
Reader sentiment
Are you bullish or bearish on MNPR?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 7 analysts
Buy
Avg price target
129.29 +54.3%
Price target rangecurrent 83.78
Low119.00
Avg129.29
High145.00
Buy 86%
Hold 14%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-28 | Piper Sandler | -- | BUY | 123.00 |
| 2026-09-21 | H.C. Wainwright | -- | BUY | 125.00 |
| 2026-09-11 | Barclays | -- | BUY | 145.00 |
| 2026-08-17 | Morgan Stanley | -- | BUY | 130.00 |
| 2026-08-13 | H.C. Wainwright | -- | BUY | 125.00 |
| 2026-08-13 | Barclays | -- | BUY | 128.00 |
| 2026-08-12 | Cantor Fitzgerald | -- | HOLD | 119.00 |
| 2026-08-12 | JonesTrading | -- | BUY | 130.00 |
| 2026-08-12 | BTIG | -- | BUY | 133.00 |
| 2026-07-23 | Barclays | -- | BUY | 125.00 |
| 2026-07-22 | BTIG | -- | BUY | 117.00 |
| 2026-07-22 | Morgan Stanley | -- | BUY | 115.00 |
| 2026-07-22 | H.C. Wainwright | -- | BUY | 125.00 |
| 2026-07-01 | BTIG | -- | BUY | 117.00 |
| 2026-06-30 | BTIG | -- | BUY | 117.00 |
| 2026-06-30 | Lake Street | -- | BUY | 103.00 |
| 2026-06-29 | JonesTrading | -- | BUY | 130.00 |
| 2026-06-29 | Piper Sandler | -- | BUY | 101.00 |
| 2026-06-29 | H.C. Wainwright | -- | BUY | 105.00 |
| 2026-06-29 | Barclays | -- | BUY | 125.00 |
| 2026-06-02 | Piper Sandler | -- | BUY | 101.00 |
| 2026-06-02 | H.C. Wainwright | -- | BUY | 105.00 |
| 2026-06-01 | BTIG | -- | BUY | 104.00 |
| 2026-06-01 | Lake Street | -- | BUY | 103.00 |
| 2026-06-01 | H.C. Wainwright | -- | BUY | 105.00 |
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 0 upgrades vs 1 downgrade among tracked analyst rating changes.
- Most recent: Cantor Fitzgerald moved from Buy to Hold on 2026-08-12.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-08-12 | Cantor Fitzgerald | BUY → HOLD | 119.00 |
Quote time 2026-10-08 08:54:52 · For reference only, not investment advice and not tailored to your situation.